img

Global Solid-phase Oligonucleotide Synthesis Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Solid-phase Oligonucleotide Synthesis Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Solid-phase Oligonucleotide Synthesis Market
Global Solid-phase Oligonucleotide Synthesis market is expected to reach to US$ 481 million in 2023, with a positive growth of %, compared with US$ 421 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Solid-phase Oligonucleotide Synthesis industry is evaluated to reach US$ 1221.2 million in 2033. The CAGR will be 16.8% during 2023 to 2033.
Globally, Solid-phase Oligonucleotide Synthesis key companies include Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics and Gene Oracle, etc. Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Solid-phase Oligonucleotide Synthesis were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Solid-phase Oligonucleotide Synthesis market and estimated to attract more attentions from industry insiders and investors.
Solid-phase Oligonucleotide Synthesis can be divided into Primers, Probes, Intermediate-scale Synthesis Oligos and Large-scale Synthesis Oligos, etc. Primers is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Solid-phase Oligonucleotide Synthesis is widely used in various fields, such as Commercial and Academic Research, etc. Commercial provides greatest supports to the Solid-phase Oligonucleotide Synthesis industry development. In 2022, global % revenue of Solid-phase Oligonucleotide Synthesis went into Commercial filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Solid-phase Oligonucleotide Synthesis market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Solid-phase Oligonucleotide Synthesis market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
Segment by Type
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors

Segment by Application


Commercial
Academic Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Solid-phase Oligonucleotide Synthesis introduction, etc. Solid-phase Oligonucleotide Synthesis Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Solid-phase Oligonucleotide Synthesis
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Primers
1.2.3 Probes
1.2.4 Intermediate-scale Synthesis Oligos
1.2.5 Large-scale Synthesis Oligos
1.2.6 Linkers and Adaptors
1.3 Market by Application
1.3.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid-phase Oligonucleotide Synthesis Market Perspective (2018-2033)
2.2 Global Solid-phase Oligonucleotide Synthesis Growth Trends by Region
2.2.1 Solid-phase Oligonucleotide Synthesis Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Solid-phase Oligonucleotide Synthesis Historic Market Size by Region (2018-2023)
2.2.3 Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2024-2033)
2.3 Solid-phase Oligonucleotide Synthesis Market Dynamics
2.3.1 Solid-phase Oligonucleotide Synthesis Industry Trends
2.3.2 Solid-phase Oligonucleotide Synthesis Market Drivers
2.3.3 Solid-phase Oligonucleotide Synthesis Market Challenges
2.3.4 Solid-phase Oligonucleotide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Solid-phase Oligonucleotide Synthesis by Players
3.1.1 Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2018-2023)
3.1.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Players (2018-2023)
3.2 Global Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Solid-phase Oligonucleotide Synthesis, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio
3.4.1 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid-phase Oligonucleotide Synthesis Revenue in 2022
3.5 Global Key Players of Solid-phase Oligonucleotide Synthesis Head office and Area Served
3.6 Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
3.7 Global Key Players of Solid-phase Oligonucleotide Synthesis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid-phase Oligonucleotide Synthesis Breakdown Data by Type
4.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Type (2018-2023)
4.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2024-2033)
5 Solid-phase Oligonucleotide Synthesis Breakdown Data by Application
5.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Application (2018-2023)
5.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
6.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Type
6.2.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023)
6.2.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033)
6.2.3 North America Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Application
6.3.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023)
6.3.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033)
6.3.3 North America Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
6.4 North America Solid-phase Oligonucleotide Synthesis Market Size by Country
6.4.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023)
6.4.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
7.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type
7.2.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023)
7.2.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033)
7.2.3 Europe Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application
7.3.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023)
7.3.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033)
7.3.3 Europe Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
7.4 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country
7.4.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023)
7.4.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
8.2 China Solid-phase Oligonucleotide Synthesis Market Size by Type
8.2.1 China Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023)
8.2.2 China Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033)
8.2.3 China Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
8.3 China Solid-phase Oligonucleotide Synthesis Market Size by Application
8.3.1 China Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023)
8.3.2 China Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033)
8.3.3 China Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
9.2 Asia Solid-phase Oligonucleotide Synthesis Market Size by Type
9.2.1 Asia Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023)
9.2.2 Asia Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033)
9.2.3 Asia Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
9.3 Asia Solid-phase Oligonucleotide Synthesis Market Size by Application
9.3.1 Asia Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023)
9.3.2 Asia Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033)
9.3.3 Asia Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
9.4 Asia Solid-phase Oligonucleotide Synthesis Market Size by Region
9.4.1 Asia Solid-phase Oligonucleotide Synthesis Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Solid-phase Oligonucleotide Synthesis Market Size by Region (2018-2023)
9.4.3 Asia Solid-phase Oligonucleotide Synthesis Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Genescript
11.1.1 Genescript Company Details
11.1.2 Genescript Business Overview
11.1.3 Genescript Solid-phase Oligonucleotide Synthesis Introduction
11.1.4 Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.1.5 Genescript Recent Developments
11.2 GeneArt (Thermofischer)
11.2.1 GeneArt (Thermofischer) Company Details
11.2.2 GeneArt (Thermofischer) Business Overview
11.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Introduction
11.2.4 GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.2.5 GeneArt (Thermofischer) Recent Developments
11.3 Renesas Electronics Corporation
11.3.1 Renesas Electronics Corporation Company Details
11.3.2 Renesas Electronics Corporation Business Overview
11.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Introduction
11.3.4 Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.3.5 Renesas Electronics Corporation Recent Developments
11.4 DNA 2.0 (ATUM)
11.4.1 DNA 2.0 (ATUM) Company Details
11.4.2 DNA 2.0 (ATUM) Business Overview
11.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Introduction
11.4.4 DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.4.5 DNA 2.0 (ATUM) Recent Developments
11.5 OriGene
11.5.1 OriGene Company Details
11.5.2 OriGene Business Overview
11.5.3 OriGene Solid-phase Oligonucleotide Synthesis Introduction
11.5.4 OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.5.5 OriGene Recent Developments
11.6 BBI
11.6.1 BBI Company Details
11.6.2 BBI Business Overview
11.6.3 BBI Solid-phase Oligonucleotide Synthesis Introduction
11.6.4 BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.6.5 BBI Recent Developments
11.7 Genewiz
11.7.1 Genewiz Company Details
11.7.2 Genewiz Business Overview
11.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Introduction
11.7.4 Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.7.5 Genewiz Recent Developments
11.8 Eurofins Genomics
11.8.1 Eurofins Genomics Company Details
11.8.2 Eurofins Genomics Business Overview
11.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Introduction
11.8.4 Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.8.5 Eurofins Genomics Recent Developments
11.9 Gene Oracle
11.9.1 Gene Oracle Company Details
11.9.2 Gene Oracle Business Overview
11.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Introduction
11.9.4 Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.9.5 Gene Oracle Recent Developments
11.10 SBS Genetech
11.10.1 SBS Genetech Company Details
11.10.2 SBS Genetech Business Overview
11.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Introduction
11.10.4 SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.10.5 SBS Genetech Recent Developments
11.11 Bio Basic
11.11.1 Bio Basic Company Details
11.11.2 Bio Basic Business Overview
11.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Introduction
11.11.4 Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
11.11.5 Bio Basic Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Primers
Table 3. Key Players of Probes
Table 4. Key Players of Intermediate-scale Synthesis Oligos
Table 5. Key Players of Large-scale Synthesis Oligos
Table 6. Key Players of Linkers and Adaptors
Table 7. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2018-2023)
Table 11. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2024-2033)
Table 13. Solid-phase Oligonucleotide Synthesis Market Trends
Table 14. Solid-phase Oligonucleotide Synthesis Market Drivers
Table 15. Solid-phase Oligonucleotide Synthesis Market Challenges
Table 16. Solid-phase Oligonucleotide Synthesis Market Restraints
Table 17. Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Players (2018-2023)
Table 19. Global Top Solid-phase Oligonucleotide Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2022)
Table 20. Global Solid-phase Oligonucleotide Synthesis Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Solid-phase Oligonucleotide Synthesis, Headquarters and Area Served
Table 23. Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
Table 24. Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2018-2023)
Table 28. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2024-2033)
Table 30. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Application (2018-2023)
Table 32. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Application (2024-2033)
Table 34. North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Solid-phase Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Solid-phase Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Solid-phase Oligonucleotide Synthesis Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Solid-phase Oligonucleotide Synthesis Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Solid-phase Oligonucleotide Synthesis Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2024-2033) & (US$ Million)
Table 66. Genescript Company Details
Table 67. Genescript Business Overview
Table 68. Genescript Solid-phase Oligonucleotide Synthesis Product
Table 69. Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 70. Genescript Recent Developments
Table 71. GeneArt (Thermofischer) Company Details
Table 72. GeneArt (Thermofischer) Business Overview
Table 73. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product
Table 74. GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 75. GeneArt (Thermofischer) Recent Developments
Table 76. Renesas Electronics Corporation Company Details
Table 77. Renesas Electronics Corporation Business Overview
Table 78. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product
Table 79. Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 80. Renesas Electronics Corporation Recent Developments
Table 81. DNA 2.0 (ATUM) Company Details
Table 82. DNA 2.0 (ATUM) Business Overview
Table 83. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product
Table 84. DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 85. DNA 2.0 (ATUM) Recent Developments
Table 86. OriGene Company Details
Table 87. OriGene Business Overview
Table 88. OriGene Solid-phase Oligonucleotide Synthesis Product
Table 89. OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 90. OriGene Recent Developments
Table 91. BBI Company Details
Table 92. BBI Business Overview
Table 93. BBI Solid-phase Oligonucleotide Synthesis Product
Table 94. BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 95. BBI Recent Developments
Table 96. Genewiz Company Details
Table 97. Genewiz Business Overview
Table 98. Genewiz Solid-phase Oligonucleotide Synthesis Product
Table 99. Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 100. Genewiz Recent Developments
Table 101. Eurofins Genomics Company Details
Table 102. Eurofins Genomics Business Overview
Table 103. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product
Table 104. Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 105. Eurofins Genomics Recent Developments
Table 106. Gene Oracle Company Details
Table 107. Gene Oracle Business Overview
Table 108. Gene Oracle Solid-phase Oligonucleotide Synthesis Product
Table 109. Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 110. Gene Oracle Recent Developments
Table 111. SBS Genetech Company Details
Table 112. SBS Genetech Business Overview
Table 113. SBS Genetech Solid-phase Oligonucleotide Synthesis Product
Table 114. SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 115. SBS Genetech Recent Developments
Table 116. Bio Basic Company Details
Table 117. Bio Basic Business Overview
Table 118. Bio Basic Solid-phase Oligonucleotide Synthesis Product
Table 119. Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2018-2023) & (US$ Million)
Table 120. Bio Basic Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Solid-phase Oligonucleotide Synthesis Market Share by Type: 2022 VS 2033
Figure 3. Primers Features
Figure 4. Probes Features
Figure 5. Intermediate-scale Synthesis Oligos Features
Figure 6. Large-scale Synthesis Oligos Features
Figure 7. Linkers and Adaptors Features
Figure 8. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Solid-phase Oligonucleotide Synthesis Market Share by Application: 2022 VS 2033
Figure 10. Commercial Case Studies
Figure 11. Academic Research Case Studies
Figure 12. Solid-phase Oligonucleotide Synthesis Report Years Considered
Figure 13. Global Solid-phase Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Solid-phase Oligonucleotide Synthesis Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Solid-phase Oligonucleotide Synthesis Market Share by Region: 2022 VS 2033
Figure 16. Global Solid-phase Oligonucleotide Synthesis Market Share by Players in 2022
Figure 17. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2022
Figure 19. North America Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
Figure 21. North America Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
Figure 22. North America Solid-phase Oligonucleotide Synthesis Market Share by Country (2018-2033)
Figure 23. United States Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Solid-phase Oligonucleotide Synthesis Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
Figure 27. Europe Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
Figure 28. Europe Solid-phase Oligonucleotide Synthesis Market Share by Country (2018-2033)
Figure 29. Germany Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Solid-phase Oligonucleotide Synthesis Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
Figure 37. China Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
Figure 38. Asia Solid-phase Oligonucleotide Synthesis Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
Figure 40. Asia Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
Figure 41. Asia Solid-phase Oligonucleotide Synthesis Market Share by Region (2018-2033)
Figure 42. Japan Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Solid-phase Oligonucleotide Synthesis Market Share by Country (2018-2033)
Figure 52. Brazil Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Genescript Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 59. GeneArt (Thermofischer) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 60. Renesas Electronics Corporation Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 61. DNA 2.0 (ATUM) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 62. OriGene Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 63. BBI Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 64. Genewiz Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 65. Eurofins Genomics Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 66. Gene Oracle Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 67. SBS Genetech Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 68. Bio Basic Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries